Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity

• DOI: 10.1377/hlthaff.2011.0382
• Publication Date: 2011-06-09T15:33:18Z
• Authors: Meghan L. Stack; Sachiko Ozawa; David M. Bishai; Andrew Mirelman; Yvonne Tam; Louis Niessen; Damian G. Walker; Orin S. Levine
• Keywords: Employment; Vaccines; 330; Immunization Programs; 1. No poverty; Efficiency; Health Care Costs; Altruism; Health Services Accessibility; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Cost of Illness; Cost Savings; 8. Economic growth; Humans; Models, Econometric

In 2010 the Bill & Melinda Gates Foundation announced a $10 billion commitment over next ten years to increase access childhood vaccines in world's poorest countries. The effort was labeled "Decade of Vaccines." This study estimates both short- and long-term economic benefits from introduction increased use six seventy-two countries 2011 2020. Increased rates vaccination against pneumococcal Haemophilus influenzae type b pneumonia meningitis, rotavirus, pertussis, measles, malaria would save 6.4 million lives avert 426 cases illness, $6.2 treatment costs, $145 productivity losses. Monetary based on this analysis can be used determine return investment immunization international community local governments, they should considered policy making.